Core Viewpoint - Zhonghong Medical (300981) has shown a mixed performance in terms of stock price and financial results, with a recent stock price increase but declining profits and revenues in the latest quarterly report [1][3]. Group 1: Stock Performance - As of February 10, 2026, Zhonghong Medical's stock closed at 13.54 yuan, up by 3.28%, with a turnover rate of 2.05% and a trading volume of 80,700 shares, amounting to a total transaction value of 109 million yuan [1]. - On the same day, the net inflow of main funds was 14.4651 million yuan, accounting for 13.26% of the total transaction value, while retail investors saw a net outflow of 11.2646 million yuan, representing 10.33% of the total [1]. Group 2: Financing and Margin Trading - In the financing and margin trading segment, on February 10, 2026, the financing buy amounted to 20.7183 million yuan, with a financing repayment of 11.4878 million yuan, resulting in a net financing increase of 9.2305 million yuan [2]. - The margin trading data indicates that 4,100 shares were sold short, with no shares being repaid, leaving a short balance of 35.52 million yuan and a total margin trading balance of 127 million yuan [2]. Group 3: Financial Performance - According to the Q3 2025 report, Zhonghong Medical's main revenue for the first three quarters was 1.864 billion yuan, reflecting a year-on-year increase of 1.38%, while the net profit attributable to shareholders was -7.2102 million yuan, a decline of 114.13% [3]. - The third quarter alone saw a revenue of 626 million yuan, down by 9.24% year-on-year, with a net profit of -12.9531 million yuan, a decrease of 170.01% [3]. - The company reported a debt ratio of 28.02%, investment income of 8.7618 million yuan, financial expenses of -17.6741 million yuan, and a gross profit margin of 10.54% [3].
中红医疗（300981）2月10日主力资金净买入1446.51万元